期刊文献+

维持性血液透析患者心血管疾病死亡的危险因素分析 被引量:13

Risk factors of cardiovascular disease mortality in maintenance hemodialysis patients
下载PDF
导出
摘要 目的探讨维持性血液透析(MHD)患者心血管疾病(CVD)死亡的危险因素。方法选取MHD患者452例,测定患者透析前的总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A1(apo A1)、载脂蛋白B(apo B)、脂蛋白a[Lp(a)]、同型半胱氨酸(Hcy)、氨基末端B型钠尿肽原(NT-proBNP)、心肌肌钙蛋白I(c Tn I)和高敏C反应蛋白(hs-CRP)水平。依据MHD患者是否合并CVD死亡事件分为CVD死亡组和未死亡组,分析MHD患者CVD死亡的危险因素。结果在MHD患者中CVD死亡组NT-proBNP、hs-CRP水平高于未死亡组(P<0.05),TC、LDL-C水平低于未死亡组(P<0.05),其他指标2个组之间差异均无统计学意义(P>0.05)。Logistic回归分析显示,NT-proBNP及hs-CRP是MHD患者CVD死亡的独立危险因素[比值比(OR)=5.698,95%可信区间(CI)1.908~17.014,P=0.002;OR=3.653,95%CI 1.249~10.165,P=0.018]。结论 MHD患者相关CVD死亡危险因素与普通人群不同。NT-proBNP和hs-CRP可能是MHD患者CVD死亡的独立危险因素。 Objective To investigate the risk factors of cardiovascular disease(CVD) mortality in maintenance hemodialysis(MHD) patients.Methods A total of 452 patients with MHD were enrolled. Total cholesterol(TC),high-density lipoprotein cholesterol(HDL-C),low-density lipoprotein cholesterol (LDL-C),apolipoprotein A1(apo A1),apolipoprotein B(apo B),lipoprotein a [Lp(a)],homocysteine (Hcy),N-terminal B-type natriuretic peptide(NT-proBNP),cardiac troponin I(cTnI) and high-sensitivity C-reactive protein(hs-CRP) were determined before dialysis. According to CVD mortality,MHD patients were classified into mortality group and non-mortality group,and the risk factors of CVD mortality were analyzed.Results The levels of NT-proBNP and hs-CRP in mortality group were higher than those in non-mortality group(P〈0.05), and the levels of TC and LDL-C were lower(P〈0.05). There was no statistical significance for the other parameters between the 2 groups(P〉0.05). Logistic regression analysis showed that NT-proBNP and hs-CRP were risk factors for CVD mortality in MHD patients [odds ratio(OR)=5.698,95% confidence interval(CI)1.908-17.014, P=0.002;OR=3.653,95%CI 1.249-10.165,P=0.018].Conclusions There are some differences for the risk factors of CVD mortality between MHD patients and general population. NT-proBNP and hs-CRP may be independent risk factors for CVD mortality in MHD patients.
作者 顾峰
出处 《检验医学》 CAS 2017年第6期486-489,共4页 Laboratory Medicine
关键词 危险因素 血液透析 心血管疾病 Risk factor Hemodialysis Cardiovascular disease
  • 相关文献

参考文献7

二级参考文献78

  • 1赵泳谊,张丽,刘翠冰.尿毒症腹膜透析患者营养状况分析[J].现代医学,2005,33(1):41-43. 被引量:4
  • 2张怡玲,吴艳,栾桂君.透析患者脂质变化的临床意义[J].透析与人工器官,2005,16(1):1-3. 被引量:2
  • 3童华诚,郭玉军,李玲,苗晓亮.B型钠尿肽及N端B型钠尿肽原水平与心力衰竭患者心功能的关系[J].检验医学,2006,21(1):58-60. 被引量:19
  • 4吕玉凤,刘必成.透析患者心血管疾病危险因素的逆流行病学现象[J].中华肾脏病杂志,2006,22(3):183-186. 被引量:13
  • 5United States Renal Data System.USRD 2003 Annual Data Report.Atlas of End Stage Renal Diseases in the United States.Bethesda,Md:Maryland National Institute of Health,National Institute of Diabetes,and Digestive and Kidney Diseases,2003.
  • 6Fleischmann E,Teal N,Dudley J,et al.Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients.Kidney Int,1999,55:1560-1567.
  • 7Kalantar-Zadeh K,Kopple JD,Kilpatrick RD,et al.Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.Am J Kidney Dis,2005,46:489-500.
  • 8Snyder J J,Foley RN,Gilbertson DT,et al.Body size and outcomes on peritoneal dialysis in the United States.Kidney Int,2003,64:1838-1844.
  • 9Gould AL,Rossouw JE,Santanello NC,et al.Cholesterol reduction yields clinical benefit:Impact of statin trials.Circulation,1998,97:946-952.
  • 10Klag M J,Ford DE,Mead LA,et al.Serum cholesterol in young men and subsequent cardiovascular disease.N Engl J Med,1993,328:313-318.

共引文献121

同被引文献97

引证文献13

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部